131
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma

ORCID Icon, , , &
Pages 2683-2692 | Published online: 24 Jun 2021

Figures & data

Table 1 Demographic Data at Baseline Showing the Mean Deviation in HVF 30–2 and the Fixed-Drug-Dose-Combinations in the Study Population

Figure 1 Graphical representation of the Mean IOP at each patient visit in the study population.

Figure 1 Graphical representation of the Mean IOP at each patient visit in the study population.

Figure 2 Humphrey’s visual field analyser charts of a patient with cup-disc ratio 0.9 showing generalized depression in 30–2 visual field charting and absence of macular splitting in 10–2 visual field charting in left eye.

Figure 2 Humphrey’s visual field analyser charts of a patient with cup-disc ratio 0.9 showing generalized depression in 30–2 visual field charting and absence of macular splitting in 10–2 visual field charting in left eye.

Figure 3 Humphrey’s visual field analyser charts of a patient with cup-disc ratio 0.9 showing a biarcuate scotoma in 30–2 visual field charting in left eye.

Figure 3 Humphrey’s visual field analyser charts of a patient with cup-disc ratio 0.9 showing a biarcuate scotoma in 30–2 visual field charting in left eye.